Crystal structure of human cytochrome P450 2D6

被引:361
作者
Rowland, P [1 ]
Blaney, FE [1 ]
Smyth, MG [1 ]
Jones, JJ [1 ]
Leydon, VR [1 ]
Oxbrow, AK [1 ]
Lewis, CJ [1 ]
Tennant, MG [1 ]
Modi, S [1 ]
Eggleston, DS [1 ]
Chenery, RJ [1 ]
Bridges, AM [1 ]
机构
[1] GlaxoSmithKline, Dept Discovery Res, Harlow CM19 5AW, Essex, England
关键词
D O I
10.1074/jbc.M511232200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 2D6 is a heme-containing enzyme that is responsible for the metabolism of at least 20% of known drugs. Substrates of 2D6 typically contain a basic nitrogen and a planar aromatic ring. The crystal structure of human 2D6 has been solved and refined to 3.0 angstrom resolution. The structure shows the characteristic P450 fold as seen in other members of the family, with the lengths and orientations of the individual secondary structural elements being very similar to those seen in 2C9. There are, however, several important differences, the most notable involving the F helix, the F-G loop, the B' helix, beta sheet 4, and part of beta sheet 1, all of which are situated on the distal face of the protein. The 2D6 structure has a well defined active site cavity above the heme group, containing many important residues that have been implicated in substrate recognition and binding, including Asp-301, Glu-216, Phe-483, and Phe-120. The crystal structure helps to explain how Asp-301, Glu-216, and Phe-483 can act as substrate binding residues and suggests that the role of Phe-120 is to control the orientation of the aromatic ring found in most substrates with respect to the heme. The structure has been compared with published homology models and has been used to explain much of the reported site-directed mutagenesis data and help understand the metabolism of several compounds.
引用
收藏
页码:7614 / 7622
页数:9
相关论文
共 76 条
[1]   ICM - A NEW METHOD FOR PROTEIN MODELING AND DESIGN - APPLICATIONS TO DOCKING AND STRUCTURE PREDICTION FROM THE DISTORTED NATIVE CONFORMATION [J].
ABAGYAN, R ;
TOTROV, M ;
KUZNETSOV, D .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1994, 15 (05) :488-506
[2]  
*ACC INC, 1999, QUANTA98 VERS 98 111
[3]   Functional analysis of CYP2D6.31 variant:: Homology modeling suggests possible disruption of redox partner interaction by Arg440His substitution [J].
Allorge, D ;
Bréant, D ;
Harlow, J ;
Chowdry, J ;
Lo-Guidice, JM ;
Chevalier, D ;
Cauffiez, C ;
Lhermitte, M ;
Blaney, FE ;
Tucker, GRT ;
Broly, F ;
Ellis, SW .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2005, 59 (02) :339-346
[4]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[5]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[6]   EXPRESSION AND ENZYMATIC-ACTIVITY OF RECOMBINANT CYTOCHROME-P450 17-ALPHA-HYDROXYLASE IN ESCHERICHIA-COLI [J].
BARNES, HJ ;
ARLOTTO, MP ;
WATERMAN, MR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (13) :5597-5601
[7]   Mechanism and structure-reactivity relationships for aromatic hydroxylation by cytochrome P450 [J].
Bathelt, CM ;
Ridder, L ;
Mulholland, AJ ;
Harvey, JN .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2004, 2 (20) :2998-3005
[8]   Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions [J].
Bertz, RJ ;
Granneman, GR .
CLINICAL PHARMACOKINETICS, 1997, 32 (03) :210-258
[9]   CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS [J].
BROOKS, BR ;
BRUCCOLERI, RE ;
OLAFSON, BD ;
STATES, DJ ;
SWAMINATHAN, S ;
KARPLUS, M .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) :187-217
[10]  
Chowdry J, 2002, BRIT J CLIN PHARMACO, V53, p443P